Results 1 -
3
of
3
for
IBRUTINIB
- ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
- ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ... CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed ...
- ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ...